This article is more than 5 years old. Information may no longer be current.

Ellex acquires canaloplasty business from iScience

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ellex Medical Lasers Limited has acquired the canaloplasty business of iScience Interventional, according to a press release.

This includes the iTrack 250 catheter and suture device for the treatment of mild to moderate glaucoma.

The business will trade as Ellex iScience Inc., according to the release.

Production of the iTrack 250 will continue out of the U.S. Food and Drug Administration-approved facility in Menlo Park, Calif. Expansion of the canaloplasty clinical training team will start immediately to better support customers, the release said.